Items Tagged ‘MammaPrint’

September 7th, 2016

MammaPrint Might Help Identify Breast Cancer Patients Who Could Safely Opt Out of Chemo


MammaPrint, a 70-gene signature test, might help healthcare providers and patients determine whether they will derive a benefit from chemotherapy, or if they could safely choose to not receive chemotherapy for early-stage breast cancer. These results need to be validated, and compared to other tests in order to confirm findings and determine true clinical utility […]

View full entry

Tags: Breast Cancer, early-stage, hereditary, MammaPrint, News, Stage I Node Negative Breast Cancer